FDA approves acyclovir buccal tablets for recurrent herpes labialis
October 15th 2013Patients randomized to acyclovir MBT experienced less time from prodromal symptoms to healing; more patients had abortive episodes that did not progress to vesicular lesions; and duration of abortive episodes was briefer.
S. 959 passage would close 40% of compounding pharmacies, survey says
September 26th 2013A new poll sent to independent compounding pharmacies by the Professional Compounding Centers of America (PCCA) found that approximately 40% of pharmacies surveyed would close their businesses under the requirements of Senate Bill 959, The Pharmaceutical Quality, Security, and Accountability Act.
Oct. 4 deadline for comments on plan for ADE prevention
September 23rd 2013The Office of Disease Prevention and Health Promotion under the Department of Health and Human Services (HHS) is calling for public review and comments on its draft plan to reduce adverse drug events that are preventable. The deadline is Friday, Oct. 4 to email feedback to ADE@hhs.gov.
Pharmacy immunizations: How to manage a successful claims process
September 15th 2013With the flu season right around the corner, pharmacies should engage payers as early in the year as possible to ensure adequate time to finalize contracting, fully test their billing capabilities, and stock inventory before the official start of the vaccine season.
Compounding pharmacies bring health plan lawsuit
September 15th 2013Massachusetts' Harvard Pilgrim Health Care has instituted a policy shift excluding coverage of prescription drugs compounded for adults. Plaintiffs call this "a callous decision" and "a major blow" to the state's many patients who depend on compounded medications.